help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amaratunga, A.
Right arrow Articles by Scott, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amaratunga, A.
Right arrow Articles by Scott, H.
Right arrowPubmed/NCBI databases
*Gene*Protein
*UniGene
*Substance via MeSH
Endocrinology Vol. 142, No. 10 4314-4319
Copyright © 2001 by The Endocrine Society


ARTICLES

Secretion of Pancreatic Icosapeptide from Porcine Pancreas

Anil Amaratunga, Bernard E. Tuch, Xu-Guang Han, Pauline Georges, Sophia K. Dean and Hayley Scott

Pancreas Transplant Unit, Prince of Wales Hospital and University of New South Wales, Sydney, New South Wales 2031, Australia

Address all correspondence and requests for reprints to: Bernard Tuch M.D., Ph.D., Pancreas Transplant Unit, Department of Endocrinology, Diabetes, and Metabolism, Prince of Wales Hospital, High Street, Randwick, New South Wales 2031, Australia. E-mail: b.tuch{at}unsw.edu.au


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The pancreatic polypeptide cell, the only mature endocrine cell in the fetal pig pancreas, produces equimolar amounts of two peptides, pancreatic polypeptide and pancreatic icosapeptide, from the same precursor. The amino acid sequence of pancreatic polypeptide is more homogenous among species, whereas pancreatic icosapeptide is heterogeneous. We determined the 19-amino acid sequence of porcine pancreatic icosapeptide, which is markedly different from that of known sequences (e.g. 47% homology with human). We developed an ELISA that can measure porcine pancreatic icosapeptide levels in the range of 7.2–480 pmol/liter. Actual levels of pancreatic icosapeptide in pig sera were 9.6–25 pmol/liter. The assay requires relatively small amounts of nonextracted samples, and human and mouse sera do not cross-react. Levels of pancreatic icosapeptide rose in response to hypoglycemia in pigs and to carbachol in fetal porcine pancreatic cells in vitro. When fetal porcine pancreatic tissue was transplanted into nonobese diabetic-severe combined immune deficiency mice, porcine pancreatic icosapeptide (but not C peptide) was detectable in mouse sera for up to 3 wk after transplantation, with levels highest on d 4. Porcine pancreatic icosapeptide and insulin were detectable in grafts removed from the mice. Therefore, porcine pancreatic icosapeptide may be used as a marker of the viability of xenotransplanted fetal pig pancreatic tissue in the immediate posttransplant period.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
XENOTRANSPLANTATION OF porcine fetal pancreatic tissue into diabetic humans is a promising line of investigation for the treatment of type 1 diabetes (1). Insulin-producing fetal pig cells are capable of normalizing blood glucose levels when transplanted into diabetic mice (2, 3, 4, 5, 6) and rats (7). The period required to achieve this goal is 1–5 months, during which time there is an increase in the mass of ß-cells and a maturation of their ability to secrete insulin when exposed to glucose. Until now it has not been possible to determine graft development or rejection during this period without removing the graft. Measuring levels of porcine insulin and C peptide is of no value, because these hormones are not released in levels measurable until several months after transplantation (1).

As an alternative to monitoring insulin levels we have examined the possibility of measuring the hormones produced by the pancreatic polypeptide (PP) cell in the pancreas. The PP cell is the first and only mature pancreatic endocrine cell to develop in the pig before birth (8). All other pancreatic hormones are colocalized in one or more cells during this time. It is only after birth that these other endocrine hormones are found in separate cells. Peptide hormones are generated through posttranslational modification of larger precursor molecules. This processing results in the formation of several stable peptide products. Two hormones are produced in the PP cell, PP and pancreatic icosapeptide (PI), from a 95-amino acid precursor (9, 10).

We have previously shown that levels of porcine PP can probably be used to monitor the viability of fetal pig pancreatic tissue transplanted into mice (11). Levels of PP were measured by RIA using an antibody that bound more to porcine than to mouse PP; these two peptides are six amino acids different from each other. Such an RIA cannot be used to measure levels of porcine PP in human serum, because pig and human peptides differ by only two amino acids. Because of the cross-over in binding, we examined the possibility of measuring the more heterogeneous PI, which should be secreted in an equimolar basis with PP.

The structures of human, ovine, and canine, but not porcine, PI have been described previously (1, 9). Human PI differs from sheep and dog PI by six and nine amino acids, respectively. Theoretically, the composition of porcine PI should differ markedly from that of human PI. It is generally believed that the structure of a biologically relevant peptide is better preserved through evolution than a peptide with a limited action. Thus, the structure of insulin is reasonably well preserved between species, but that of C peptide is not.

We set out to determine the sequence of porcine PI, develop an assay to measure it, and show how it is secreted physiologically. We also determined its usefulness in monitoring the viability of xenotransplanted fetal pig pancreatic cells.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Sequence determination of porcine PI
The cDNA sequence for the 3'-end of porcine PP was cloned by rapid amplification of cDNA 3'-ends (3'RACE) technology. A partial degenerate primer was made based on the amino acid sequence for the porcine PP (SWISS-PROT: PO 1300) and comparison with the published cDNA sequences of other species. The sequence of primer 5'-gcccc(a/g/c)ctggagcc(a/t)gtgta corresponds to the first 7 of the 36 porcine PP amino acids, Ala-Pro-Leu-Glu-Pro-Val-Tyr. The 3'RACE reactions were performed according to the manufacturer’s instructions (Life Technologies, Inc., Grand Island, NY) with total RNA extracted from porcine pancreatic islets. The PCR product was cloned into a PCR II vector (Invitrogen, San Diego, CA) and sequenced by SUPAMAC (Sydney, Australia) using an automated ABI 377 DNA sequencer. Additional PCR reactions were performed to confirm the correct cloning with nested primers made based on the initial sequence.

Raising antibodies to porcine PI
The amino acid composition of porcine PI was deduced from the cDNA sequence determined, and the peptide was then synthesized (Auspep, Parkville, Australia). Next, polyclonal antibodies to synthetic porcine PI were raised in rabbit and sheep (Institute of Medical and Veterinary Science, Adelaide, Australia). The peptide was conjugated to keyhole limpet hemocyanin before immunization. Preimmune and immune sera were tested for binding with the synthetic peptide by a direct ELISA. For this, 96-well microtiter plates (Maxisorp immunoplates, Nunc International, Naperville, IL) were coated at 4 C overnight with 10 µg/ml synthetic peptide in coating buffer (0.1 M NaHCO3 buffer, pH 8.3). The wells were blocked for 1 h at room temperature using PBS containing 1% BSA (blocking buffer). Sera diluted to 102, 103, 104, and 105 by PBS containing 0.25% BSA and 0.1% Tween (assay buffer) were added to the wells for 2 h at room temperature, followed by a similar incubation with horseradish peroxidase (HRP) conjugated to rabbit or sheep IgG as the secondary antibody. The wells were washed before and after incubation with PBS containing 0.1% Tween (wash buffer). Color development was achieved with 3,3',5,5'-tetramethylbenzidine peroxidase substrate (KPL Laboratories, Inc., Gaithersburg, MD), with 0.18 M H2SO4 added to stop the development (stop solution). Color intensity was measured using a Microplate Reader (Multiscan, Labsystems, Helsinki, Finland).

IgG was purified from sera using protein A (for rabbit sera) or protein G (for sheep sera). Sera were mixed 1:1 with 0.05 M Tris buffer, pH 7.2, and centrifuged for 10 min at 10,000 rpm. Supernatant was loaded on to a column of protein A or protein G conjugated to agarose (Pierce Chemical Co., Rockford, IL). The column was then washed with 10 column vol using the same buffer to remove unbound and nonspecifically bound proteins and other components. IgG bound to the column was eluted by using 0.05 M glycine, pH 2.5. Fractions of 1 ml were collected, and protein levels in the fractions were determined by Bradford assay. Typically, 80% of the eluted IgG was present in a single fraction, and all IgG was present in three fractions. These three fractions (3 ml) were pooled and concentrated by centrifuging in a Centriprep-30 filter (Millipore Corp., Bedford, MA) at 1,500 x g. The concentrated volume (~0.3 ml) was dialyzed against PBS using a dialysis cassette (Pierce Chemical Co., Rockford, IL) for 1 d. Protein levels were determined in the purified IgG, followed by another direct ELISA to confirm the activity.

Antigen inhibition assay for PI
An antigen inhibition assay was developed to measure PI levels in samples using the biotin-neutravidin system for amplification of the signal. For this, IgG, purified as described above, was conjugated to biotin according the manufacturer’s instructions (Pierce Chemical Co.).

The antigen inhibition assay was set up as follows. Ninety-six-well microtiter plates were coated overnight using 10 µg/ml of the peptide in coating buffer. Plates were blocked for 1 h at room temperature using the blocking buffer. A 2-fold dilution series of PI standards (staring from 1000 pg/ml) was prepared using the assay buffer. One hundred microliters of the standards or samples and 400 µl biotin-IgG (1.2 µg/ml) were mixed in microfuge tubes for 2 h at room temperature on a rotator. The concentration of biotin-IgG required for the antigen inhibition assay was determined by a dilution assay. Triplicates of 100 µl/well were added to the plate (after blocking) and incubated for 1 h at room temperature. This was followed by a 1-h room temperature incubation with a Neutravidin (1.0 µg/ml) and biotin-HRP (250 ng/ml) mixture (100 µl/well). Washing of wells before and after incubations was carried out with the washing buffer. The substrate, 3,3',5,5'-tetramethylbenzidine peroxidase, was added (100 µl/well), and the color development reaction was allowed to proceed for 1 h. Then the stop solution was added, and OD was measured at 450 nm.

Pig studies
The following experiments were carried out with the approval of the animal care and ethics committee of our institution. Juvenile Large White Landrace pigs were anesthetized, and a catheter inserted into the jugular vein (12, 13). Animals were fasted overnight, and the next morning an insulin tolerance test was performed with an iv injection of 0.1 U soluble insulin/kg body weight. Blood was collected at 0, 5, 10, 15, 20, 30, 35, 40, 45, 50, and 60 min for measurement of glucose, PP, and PI levels. PP levels were determined using an RIA kit (Phoenix Pharmaceuticals, Inc., Belmont, CA), which uses a human standard (77% cross-reactivity with porcine PP).

Fetal pig pancreas
Fetal pigs were removed from freshly killed Large White Landrace sows of gestational age 75–100 d (normal period of gestation, 118 d). The fetal pigs were air-freighted on ice to reach the investigators in Sydney within 4 h of death. Pancreases were removed from the fetuses and digested to produce islet-like cell clusters (ICCs) by exposure to collagenase P, as described previously (2, 14). These clusters of cells round up after 2–3 d in culture medium RPMI containing 11.1 mM glucose supplemented with antibiotics and 10% FCS.

Measurement of PI in fetal pancreatic tissue
Fetal pancreatic tissue was homogenized in acid-ethanol, followed by overnight incubation at 4 C. After centrifugation at 10,000 rpm for 10 min, the supernatant was neutralized by adding 1.0 mM Na2CO3, pH 8.5, and assayed for levels of PI.

Secretion of PI from pig tissue in vitro
ICCs were removed on the third day of culture and placed in groups of 200 in Eppendorf tubes. They were washed twice with HEPES-buffered Earle’s medium, which consists of 124 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 1 mM NaH2PO4, 14.3 mM NaHCO3, and 2 mM glucose supplemented with 0.2% BSA (Sigma) and 10 mM HEPES. The ICCs were then washed with medium containing the stimulus 10 mM carbamylcholine chloride (carbachol; Sigma) before being exposed to it for 2 h. The tubes were then centrifuged, and the supernatant was collected for measurement of PI.

Transplantation of pancreatic explants into nonobese diabetic-severe combined immune deficiency (NOD-SCID) mice
The following experiments were carried out with the approval of the animal care and ethics committee of our institution. Uncultured 1-mm3 fragments of fetal pig pancreas were transplanted beneath the renal capsule of NOD-SCID mice as described previously (6). The weight of tissue grafted beneath the renal capsule was 24.05 ± 8.86 mg (mean ± SD; n = 22). Animals were euthanized with CO2 at different times after transplantation ranging from 4 d to 3 wk, with blood collected from the beating heart for measurement of PI and porcine C peptide levels. To optimize the secretion of PI in the grafted mice, an ip injection of 4.1 mol/kg carbachol was given 2 min before the animals were killed (11). After death, the kidneys were exposed, and the grafts, which were pearly white, slightly raised masses on the surface of the kidneys, were shelled out. PI and insulin were extracted by homogenization of the tissue in acid-ethanol and overnight incubation at 4 C. Porcine C peptide was measured by RIA (Linco Research, Inc., St. Charles, MO), and insulin was determined by an in-house RIA using a human standard (Novo, Bagsvaerd, Denmark).

Statistics
Data were analyzed using one-way ANOVA, with Duncan’s test (P < 0.05) applied to separate the groups, or t test. The computer statistical package NCSS was used for all analysis (15).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Porcine PI sequence
The 3'-end sequence of the porcine PP cDNA, which included the PI, was cloned using PCR-based technology (Fig. 1AGo; GenBank accession no. AF203915). This sequence contained the C-terminal part of PP followed by the rest of the gene. The deduced amino acid sequence of the peptide is shown in Fig. 1BGo. The three amino acids, glycine-lysine-arginine, which separate PP and PI (and thus provide cleavage sites) were similar in both pig and human (Fig. 1BGo). Therefore, the porcine PI sequence was assumed to start with the next amino acid, Asp, as occurs in the peptides from sheep and dog (Fig. 1BGo). Human, ovine, and canine PI are 20 amino acids long with a C-terminal cleavage site between arginine and glutamine. Porcine PI was also assumed to end at this site, thus making it 19 amino acids long with the last 6 amino acids being mostly homologous with PI of the other three species. The sequence of PI in pigs was 47%, 58%, and 53% homologous with that in humans, sheep, and dogs, respectively (10).



View larger version (45K):
[in this window]
[in a new window]
 
Figure 1. A, Porcine cDNA 3'-end of the PP gene. The sequence of PI is underlined. The amino acid sequence of the gene appears beneath the codons. B, The amino acid sequence of PI (underlined) and those of flanking sequences (if known) in pig (1 ) are compared with those in the human (2 ), sheep (3 ), and dog (4 ).

 
Assay for PI
In the ELISA developed to measure PI, the optimal concentration of measurable PI was 15–1000 pg/ml (7.2–480 pmol/liter; Fig. 2Go). The interassay coefficient of variability was 6.8 ± 3.4% (n = 5), and the intraassay coefficient of variability was 7.8 ± 3.4% (n = 5). At concentrations below 15 pg/ml (7.2 pmol/liter), the OD readings were the same as the background reading of 0.35 ± 0.01 (n = 12). Therefore, 15 pg/ml (OD, 0.31 ± 0.01; n = 12) was considered the lower limit of detection of the assay, and OD readings above 0.31 were thus considered undetectable.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2. A representative standard curve from an immunoassay for PI.

 
Porcine sera collected in the fasting state tested positively in the assay (25 ± 10 pg/ml; 12 ± 4.8 pmol/liter; mean ± SD; n = 4). Samples obtained in the nonfasting state were more variable (20–53 pg/ml; 9.6–25 pmol/liter; n = 6), but still within the range of the assay. The PI content of fetal pig pancreatic tissue was 0.40 ± 0.05 pmol/mg tissue (mean ± SD; n = 4 pancreases). Human and mouse sera gave OD readings of 0.34 ± 0.01, (n = 12) and 0.39 ± 0.02, (n = 10), respectively, and were thus considered noncross-reactive with the assay.

Effect of hypoglycemia on PI levels in pigs
Hypoglycemia induced in pigs (Fig. 3AGo) caused a counterregulatory increase in the level of PP, as expected (Fig. 3BGo). As PI should be secreted on an equimolar basis with PP, levels of PI should also rise in response to hypoglycemia. This was observed (Fig. 3CGo), with the increase in PI being parallel to that in PP. The subsequent fall in PI levels also was parallel to that in PP. The ratio of PP/PI throughout the test was 0.96 ± 0.07 (mean ± SEM; n = 32). These data show that PI is secreted in response to the same stimulus as PP and support the concept that these two hormones are secreted on an equimolar basis.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. Levels of blood glucose (A), serum PP (B), and serum PI (C) in pigs injected with insulin after overnight fasting. There were four values at each time point from 0 to 1 h. Data are expressed as the mean ± SEM.

 
Secretion of PI from fetal pig ICCs
Fetal pig ICCs secreted PI with levels being enhanced when exposed to the cholinergic agent, carbachol. The basal level of PI secretion over 2 h was 5.61 ± 0.37 fmol/200 ICCs (mean ± SEM; n = 16). Carbachol significantly increased the secretion of PI to 8.29 ± 0.59 fmol/200 ICCs (mean ± SEM; n = 16); the percent increase was 48 ± 16% (P = 0.001).

Secretion of porcine PI in grafted NOD-SCID mice
Porcine PI was measurable in the blood of NOD-SCID mice transplanted with fetal pig ICCs for at least 3 wk after the tissue was transplanted (Fig. 4AGo). These levels were measured after stimulation with carbachol. Levels were highest at 4 d (P < 0.001; 19.69 ± 1.00 pmol/liter; n = 6), with the values at 1, 2, and 3 wk relatively similar. The blood of untransplanted mice gave readings in the PI assay no different from background. Porcine C peptide was undetectable in all blood samples of the transplanted mice.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Levels of PI and insulin in NOD-SCID mice transplanted with fetal porcine pancreatic explants. PI values are measured in blood (A) and the graft (B), and insulin values are measured in the graft (C) at 4 d and 1, 2, and 3 wk after transplantation. There were five or six values at each time point. Data are expressed as the mean ± SEM. *, P < 0.001, d 4 > all other times. **, P = 0.013, wk 1 < wk 2 and 3.

 
PI and insulin were measurable in the grafts removed from mice at all four time points. Levels of PI were greater at wk 2 and 3 than at wk 1 (P = 0.013; Fig. 4BGo). Levels of insulin were not significantly different from one another (Fig. 4CGo). These data confirm that the grafts remained viable for the duration of the experiment. However, the secretion of these hormones from the grafts did not correlate with their respective hormonal content.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have described in this paper, for the first time, the structure of porcine PI, which together with PP is generated by cleavage from a precursor prohormone in the PP cell of the pancreas. Previous studies have identified the PI sequences of human, dog, and sheep (9, 10). Our cloned pig sequence included the last 30 of the 36 known amino acids of PP, followed by a new sequence of 29 amino acids. By comparison with human, dog, and sheep PI sequences, we identified flanking amino acids outside the N- and C-terminals of the PI sequence, thereby deducing a 19-amino acid sequence for porcine PI. As expected, the porcine PI sequence was markedly different from the other known PI sequences, although the PP sequences of these species share very similar homology.

The sequence heterology of PI may be comparable to that observed in the C peptide, which is cleaved off from proinsulin during insulin synthesis. Human and porcine insulin sequences differ by a single amino acid, whereas the C peptides show only 70% homology. Human and porcine PP sequences differ by two amino acids, whereas the cleaved icosapeptides show only 47% homology. Further, PP does have a physiological function in inhibiting exocrine enzyme secretion and bile acid secretion (16), whereas no functions are known for PI or C peptide.

This sequence heterology of PI is of potential importance in xenotransplantation of pig tissue. Xenotransplantation of fetal pancreatic pig cells is being explored by a number of investigators as an alternative method for the treatment of type 1 diabetes (1, 2, 3, 4, 5, 6). The period taken to achieve normalization of blood glucose levels is 1–5 months, during which time maturation of the ß-cell occurs. The only mature endocrine cell at the time of transplantation is the PP cell (8). Maturation of the graft is accompanied by a gradual increase in the number of ß-cells and a corresponding decrease in PP cells. From our previous immunohistochemical studies, PP cells, which comprise 9% of all epithelial cells in the graft at the time of transplantation, increased immediately after transplantation (17% at 4 d and at 3 wk, 21%) (11). Thereafter, the percentage of PP cells diminished (9% at 12 wk). In contrast, ß-cells, which comprised 12% of the epithelial cells in the graft at the time of transplantation, did not increase immediately thereafter (13% at 4 d). It was only at 3 wk and beyond that the percentage of these cells rose, reaching 34% at 12 wk. For this reason and because the fetal ß-cell is immature in its ability to secrete insulin in response to glucose, it is understandable that porcine C peptide is not detectable in host serum during the first few weeks after transplantation (porcine insulin cannot be fully distinguished from mouse insulin because of sequence homology). Thus, porcine insulin or C peptide cannot be used to monitor the viability of the graft.

We hypothesized that hormones secreted from the mature PP cell could be used for this purpose. Previously we have shown that PP secretion could probably be used as a marker of viability at this time (11). However, because of sequence homology between species, it was not possible to fully separate pig PP from that of other species, especially mouse and human. Porcine PI, another hormone secreted from the PP cell, can be fully distinguished from mouse and human PI. Its measurement in the blood of mice transplanted with fetal pig pancreatic tissue confirms our hypothesis that monitoring secretion of hormones from the PP cell is useful to monitor the viability of the grafted tissue.

Physiologically PP (and PI) is secreted from PP cells in the pancreas in response to a vagal stimulus, such as hypoglycemia or eating food (16). As vagal innervation of pancreas transplants does not occur, the secretion of PP (and PI) from such grafts cannot be enhanced by vagal stimulation (17). Exposure of the grafts to a cholinergic agent, carbachol, directly stimulated PP release from the graft (11). Therefore, the same stimulus, carbachol, was used in the current study to measure PI release from the graft.

As expected, carbachol stimulation of the relatively large number of PP cells in the graft during the experimental period enabled us to detect porcine PI in mouse serum. Levels of PI were highest 4 d after fetal pig pancreatic tissue was transplanted into the mice, but were still measurable for at least the next 17 d (Fig. 4AGo). No attempt was made to measure levels of PI earlier than 4 d, but based on previous experiments it would be expected that PI would be measurable earlier than this (11). Our current results are similar to those reported previously when serum levels of PP were used as a marker of graft viability for up to 3 wk after transplantation, but was absent thereafter (11). In a separate study (unpublished) by the authors in which diabetic mice were transplanted, we confirmed that serum PI is not detectable after this time. In contrast, the ß-cell does not secrete detectable levels of C peptide during this time. Thus, the fetal pig PP cell, which is the least prevalent of all pancreatic endocrine cells, secretes measurable levels of its hormones for at least the first 3 wk after pancreatic tissue is transplanted. The time at which the ß-cell becomes functional varies depending on the glycemic status of the recipient. If the animal is normoglycemic, serum C peptide is immeasurable before 12 wk (11), but if the animal is hypoglycemic, C peptide is immeasurable from 3 wk (unpublished data).

The secretion of PI from the graft did not correlate with the PI content of the grafts during the experimental period, probably indicating different signaling mechanisms required for synthesis/storage and regulated secretion. The same was true for insulin, where grafts showed its synthesis/storage (11).

The assay for porcine PI does not cross-react with human sera. This indicates that either human PI is not present in sufficient amounts in the sera to evoke a reaction or, if present in sufficient amounts, is noncross-reactive with the assay (due to significant heterology with porcine PI). Either way, monitoring levels of porcine PI may be useful in assessing the viability of fetal pig pancreatic tissue in the first few weeks after it is transplanted into humans. This is a noninvasive technique for monitoring graft viability, in contrast to biopsy, which is the method currently used (1).

To be of potential benefit, the measurement of PI should be possible with small amounts of sera, carried out rapidly, and be sensitive, specific, and reproducible. We have achieved these goals with an antigen inhibition ELISA using polyclonal antibodies against PI. This form of ELISA was used in preference to a sandwich ELISA because of its greater sensitivity. Antigen-antibody contact occurs in an Eppendorf tube and not in the well of a microtiter plate, thereby increasing contact between antigen and antibody. The amplification and detection system of biotin-neutravidin-HRP was selected because of its higher sensitivity compared with other systems, such as biotin-HRP and biotin-strepavidin-HRP. The ELISA developed allowed measurement of PI between 15–1000 pg/ml (7.2–480 pmol/liter), which is within the expected level of PI in pigs (12–68 pg/ml; 6–33 pmol/liter) (18, 19, 20, 21). The assay was rapid (performed within 6 h) and required only a small volume of sample (100 µl). The specificity of the assay for pig samples was confirmed when human and mouse sera were tested and gave readings similar to background. This also demonstrated that pig serum can be used directly for PI detection without the need to extract the peptide, a method that requires a large volume of sample, is time consuming, and introduces more variability.

Secretion of PP from PP cells is enhanced by a vagal stimulus, such as hypoglycemia or food intake, and by cholinergic agents such as carbachol (16, 17). As PP and PI are cleaved from the same precursor and secreted, PI secretion also should be enhanced by vagal stimuli and cholinergic agents. We found this to be true. Hypoglycemia induced in pigs caused a rise in levels of PI, whereas carbachol enhanced secretion of PI from ICCs in vitro. The secretion of PP and PI should be equimolar, as 1 mol PP precursor is cleaved to 1 mol PI and 1 mol PP. Our results in the pigs are consistent with this if it is assumed that the rate of clearance of the two peptides is similar, with the ratio of serum levels of PP to PI being 0.96.

In summary, we have sequenced porcine PI and developed a sensitive and specific ELISA to measure it. Levels of PI rise in response to hypoglycemia and a cholinergic stimulus and can be used to monitor the viability of xenotransplanted fetal pig pancreatic tissue.


    Footnotes
 
This work was supported by Autogen Pty. Ltd.

Abbreviations: HRP, Horseradish peroxidase; ICC, islet-like cell clusters; NOD-SCID, nonobese diabetic-severe combined immune deficiency; PI, pancreatic icosapeptide; PP, pancreatic polypeptide; 3'RACE, rapid amplification of cDNA 3'-ends.

Received March 7, 2001.

Accepted for publication June 12, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Groth CG, Korsgren O, Tibell A, et al. 1994 Transplantation of fetal pancreas to diabetic patients. Lancet 344:1402–1404[CrossRef][Medline]
  2. Korsgren O, Jansson L, Eizirik D, Anderson A 1991 Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice. Diabetologia 34:379–386[CrossRef][Medline]
  3. Liu X, Federlin KF, Bretzel RG, Hering BJ, Brendel MD 1991 Persistent reversal of diabetes by transplantation of fetal pig proislets into nude mice. Diabetes 40:858–866[Abstract]
  4. Mandel TE, Koulmanda M 1995 Xenotransplantation of fetal pig pancreas and reversal of diabetes in spontaneously diabetic NOD mice. Transplant Proc 27:2179–2180[Medline]
  5. Thompson SC, Mandel TE 1990 Fetal pig pancreas. Transplantation 49:571–581[Medline]
  6. Tuch BE, Casamento FM 1999 Outcome of xenografted fetal porcine pancreatic tissue is superior in inbred scid (c.B-17/lcr-scid/scid) compared to outbred nude (cd-1-nu/nu) mice. Cell Transplant 8:259–264[Medline]
  7. Korsgen O, Jansson L 1994 Porcine islet-like cell clusters cure diabetic nude rats when transplanted under the kidney capsule, but not when implanted into the liver or spleen. Cell Transplant 3:49–54[Medline]
  8. Lukinius A, Ericsson J, Grimelius L, Korsgrn O 1992 Ultrastructural studies of the ontogeny of fetal human and porcine endocrine pancreas, with special reference to colocalisation of the four major islet hormones. Dev Biol 153:376–385[CrossRef][Medline]
  9. Boel E, Schwartz T, Norris K, Fill N 1984 A cDNA encoding a small common precursor for human pancreatic polypeptide and pancreatic icosapeptide. Eur Mol Biol J 3:909–912[Medline]
  10. Schwartz TW 1984 Human pancreatic icosapaptide: isolation, sequence and immunocytochemical localisation of the cooh-terminal fragment of the pancreatic polypeptide precursor. Proc Natl Acad Sci USA 81:708–712[Abstract/Free Full Text]
  11. Tuch BE, Tabin M, Casamento F, Yao M, Amaratunga A, Pinto A 2001 Role of pancreatic polypeptide levels as a marker of transplanted insulin-producing fetal pig cells. Cell Transplant 10:285–293[Medline]
  12. Tuch BE, Wright DC, Martin TE, et al. 1999 Differentiation of fetal pig endocrine cells after allografting into the thymus gland. Transplantation 67:1184–1187[CrossRef][Medline]
  13. Tuch BE, Simpson AM, Smith MSR, et al. 1995 Basic biology of pig fetal pancreas and its use as an allograft. In: Peterson CM, Jovanovic-Peterson L, Formby B, eds. Fetal islet transplantation. New York: Plenum Press; 51–68
  14. Korsgren O, Sandler S, Landstrom AS, Jansson L, Andersson 1988 A. Large scale production of fetal porcine pancreatic islet like cell cluster. Transplantation 45:509–514[CrossRef][Medline]
  15. Hintze JL 1991 Number cruncher statistical system 97 for Windows, version 5.01. Kaysville: Number Cruncher Statistical Systems
  16. Schwartz TW 1983 Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85:1411–1425[Medline]
  17. Diem P, Redmon J, Abid M, et al. 1990 Glucagon, catecholamine and pancreatic polypeptide secretion in type 1 diabetic recipients of pancreatic allografts. J Clin Invest 86:2008–2013
  18. Revhaug A, Lygren I, Lundgren TI, et al. 1985 Release of gastrointestinal hormones in cardiopressive shock. Acta Anaesthesiol Scand 29:371–374[Medline]
  19. Jacobsen J, Sofel T, Warber G, Secher NH 1990 Cardiovascular and endocrine responses to haemorrage in the pig. Acta Physiol Scand 138:167–173[Medline]
  20. Shokouth-Amiri MH, Rahimi-Saber S, Andersen HO, Jensen SL 1996 Pancreas autotransplantation on pig with systemic or portal venous drainage. Transplantation 61:1004–1009[CrossRef][Medline]
  21. Wettergren A, Wojdemann M, Holst JH 1998 Glucagon-like peptide 1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol 275:G984–G992




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amaratunga, A.
Right arrow Articles by Scott, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amaratunga, A.
Right arrow Articles by Scott, H.
Right arrowPubmed/NCBI databases
*Gene*Protein
*UniGene
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals